Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 26 Issue: 5
Author(s): Wei Wang
Affiliation:
Export Options
About this article
Cite this article as:
Wang Wei , Meet Our Editorial Board Member, Current Medicinal Chemistry 2019; 26 (5) . https://dx.doi.org/10.2174/092986732605190422092703
DOI https://dx.doi.org/10.2174/092986732605190422092703 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
18
3
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Current Gene Expression Studies in Esophageal Carcinoma
Current Genomics The Safety of Bisphosphonate Use in Premenopausal Women on Corticosteroids
Current Drug Safety STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Nucleosides with Modified Sugar Ring: Synthesis and Biological Activities
Current Organic Chemistry Synthesis of Fluorine-18-Labelled Choline (<sup>18</sup>F-Fluorocholine): Towards an Early and Accurate Management of Prostate Cancer in Malaysia
Current Medical Imaging Synthesis and Anticancer Activity of 7,8-dihydroxy-4-arylcoumarins
Letters in Drug Design & Discovery Harnessing the Tumor Suppressor Function of FOXO as an Alternative Therapeutic Approach in Cancer
Current Drug Targets Tissue Transglutaminase Expression During Neural Differentiation of Human Mesenchymal Stem Cells
CNS & Neurological Disorders - Drug Targets New Multidrug Resistance Reversal Agents
Current Drug Targets Recent Trends in the Design, Synthesis and Biological Exploration of β-Lactams
Current Medicinal Chemistry MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Current Cancer Drug Targets Patent Selections:
Recent Patents on Biomarkers Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
Current Topics in Medicinal Chemistry Mining the Genome for Susceptibility to Complex Neurological Disorders
Current Molecular Medicine Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Current Pharmaceutical Design The PYRIN Domain in Signal Transduction
Current Protein & Peptide Science Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews